VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q40136180 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241121000210.0
008 241121nneanz||abbn n and d
035 ‎‡a (WKP)Q40136180‏
024 ‎‡a 0000-0002-8263-1265‏ ‎‡2 orcid‏
024 ‎‡a 7501845934‏ ‎‡2 scopus‏
035 ‎‡a (OCoLC)Q40136180‏
100 0 ‎‡a Marcus Herbert Jones‏ ‎‡c investigador‏ ‎‡9 ast‏
375 ‎‡a 1‏ ‎‡2 iso5218‏
400 0 ‎‡a মার্কাস হারবার্ট জোন্স‏ ‎‡c গবেষক‏ ‎‡9 bn‏
400 0 ‎‡a Marcus Herbert Jones‏ ‎‡c researcher‏ ‎‡9 en‏
400 0 ‎‡a Marcus Herbert Jones‏ ‎‡c investigador‏ ‎‡9 es‏
400 0 ‎‡a Marcus Herbert Jones‏ ‎‡c ricercatore‏ ‎‡9 it‏
400 0 ‎‡a Marcus Herbert Jones‏ ‎‡c wetenschapper‏ ‎‡9 nl‏
670 ‎‡a Author's An official American Thoracic Society/European Respiratory Society statement: pulmonary function testing in preschool children‏
670 ‎‡a Author's An official American Thoracic Society workshop report: optimal lung function tests for monitoring cystic fibrosis, bronchopulmonary dysplasia, and recurrent wheezing in children less than 6 years of age.‏
670 ‎‡a Author's Azithromycin administered for acute bronchiolitis may have a protective effect on subsequent wheezing‏
670 ‎‡a Author's Azithromycin therapy in hospitalized infants with acute bronchiolitis is not associated with better clinical outcomes: a randomized, double-blinded, and placebo-controlled clinical trial.‏
670 ‎‡a Author's Burden of asthma among inner-city children from Southern Brazil‏
670 ‎‡a Author's Changes in the prevalence of asthma and allergic diseases among Brazilian schoolchildren‏
670 ‎‡a Author's Changes in the prevalence of asthma and allergic diseases among Brazilian schoolchildren (13-14 years old): comparison between ISAAC Phases One and Three.‏
670 ‎‡a Author's Chorioamnionitis and subsequent lung function in preterm infants‏
670 ‎‡a Author's Clinical characteristics of children and adolescents with severe therapy-resistant asthma in Brazil‏
670 ‎‡a Author's Diagnosis of Primary Ciliary Dyskinesia. An Official American Thoracic Society Clinical Practice Guideline‏
670 ‎‡a Author's Diagnosis of pulmonary aspiration: a mouse model using a starch granule test in bronchoalveolar lavage.‏
670 ‎‡a Author's Early termination of exhalation: effect on spirometric parameters in healthy preschool children‏
670 ‎‡a Author's Effect of Angiostrongylus costaricensis extract on eosinophilic pulmonary response in BALB/c mice‏
670 ‎‡a Author's Effect of continuous positive airway pressure on forced expiratory flows in infants with tracheomalacia.‏
670 ‎‡a Author's Effect of different helminth extracts on the development of asthma in mice: The influence of early-life exposure and the role of IL-10 response.‏
670 ‎‡a Author's Effect of preterm birth on airway function and lung growth.‏
670 ‎‡a Author's Effect of yogurt containing Bifidobacterium animalis subsp. lactis DN-173010 probiotic on dental plaque and saliva in orthodontic patients‏
670 ‎‡a Author's Effects of physical activity in telomere length: Systematic review and meta-analysis.‏
670 ‎‡a Author's Evaluating bronchodilator response in pediatric patients with post-infectious bronchiolitis obliterans: use of different criteria for identifying airway reversibility.‏
670 ‎‡a Author's Evaluation of airway reactivity and immune characteristics as risk factors for wheezing early in life.‏
670 ‎‡a Author's Flow limitation in infants assessed by negative expiratory pressure‏
670 ‎‡a Author's Forced expiratory flows and volumes in infants. Normative data and lung growth.‏
670 ‎‡a Author's Forced expiratory maneuvers in very young children. Assessment of flow limitation‏
670 ‎‡a Author's Genetic variation in vascular endothelial growth factor-a and lung function‏
670 ‎‡a Author's Growth rate of lung function in healthy preterm infants.‏
670 ‎‡a Author's Helminth extracts inhibit eosinophilic inflammation in a murine model of allergic rhinitis‏
670 ‎‡a Author's Impact of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) on childhood pneumonia hospitalizations in Brazil two years after introduction‏
670 ‎‡a Author's Infection of BALB/c mice with Angiostrongylus costaricensis decreases pulmonary inflammatory response to ovalbumin‏
670 ‎‡a Author's Intestinal helminth infestation is associated with increased bronchial responsiveness in children‏
670 ‎‡a Author's Levels of Th1 and Th2 cytokines in children with post-infectious bronchiolitis obliterans‏
670 ‎‡a Author's Neutrophilic airway inflammation is a main feature of induced sputum in nonatopic asthmatic children.‏
670 ‎‡a Author's Normal values for respiratory muscle strength in healthy preschoolers and school children‏
670 ‎‡a Author's Nutritional errors in the first months of life and their association with asthma and atopy in preschool children‏
670 ‎‡a Author's Peripheral glucocorticoid sensitivity in children with controlled persistent asthma.‏
670 ‎‡a Author's Plasma brain-derived neurotrophic factor levels are associated with clinical severity in school age children with asthma.‏
670 ‎‡a Author's Plastic bronchitis in a child with thalassemia alpha‏
670 ‎‡a Author's Prediction equations for spirometry in four- to six-year-old children‏
670 ‎‡a Author's Prevalence and impact of asthma in schoolchildren in the city of Caxias do Sul-RS‏
670 ‎‡a Author's Prevention of New Respiratory Episodes in Children with Recurrent Respiratory Infections: An Expert Consensus Statement‏
670 ‎‡a Author's Rate constant for forced expiration decreases with lung growth during infancy‏
670 ‎‡a Author's Recombinant human deoxyribonuclease attenuates oxidative stress in a model of eosinophilic pulmonary response in mice‏
670 ‎‡a Author's Recombinant human deoxyribonuclease therapy improves airway resistance and reduces DNA extracellular traps in a murine acute asthma model‏
670 ‎‡a Author's Reduced lung function in healthy preterm infants in the first months of life.‏
670 ‎‡a Author's Reference ranges for interrupter resistance technique: the Asthma UK Initiative.‏
670 ‎‡a Author's Reference values for spirometry in Brazilian children‏
670 ‎‡a Author's Respiratory viral coinfection and disease severity in children: A systematic review and meta-analysis‏
670 ‎‡a Author's [Rhinovirus and acute bronchiolitis in young infants].‏
670 ‎‡a Author's Risk factors for need of mechanical ventilation in children with influenza A(H1N1)pdm09.‏
670 ‎‡a Author's Sensitivity of spirometric measurements to detect airway obstruction in infants.‏
670 ‎‡a Author's Severe lower respiratory tract infection in infants and toddlers from a non-affluent population: viral etiology and co-detection as risk factors‏
670 ‎‡a Author's Spirometry centile charts for young Caucasian children: the Asthma UK Collaborative Initiative‏
670 ‎‡a Author's The burden of single virus and viral coinfections on severe lower respiratory tract infections among preterm infants: a prospective birth cohort study in Brazil‏
670 ‎‡a Author's The Impact of Respiratory Syncytial Virus Disease Prevention on Pediatric Asthma‏
670 ‎‡a Author's The prevalence of symptoms of sleep-disordered breathing in Brazilian schoolchildren.‏
670 ‎‡a Author's TNF-a and IL-10 levels in tracheobronchial lavage of ventilated preterm infants and subsequent lung function‏
909 ‎‡a (orcid) 0000000282631265‏ ‎‡9 1‏
909 ‎‡a (scopus) 7501845934‏ ‎‡9 1‏
919 ‎‡a referencevaluesforspirometryinbrazilianchildren‏ ‎‡A Reference values for spirometry in Brazilian children‏ ‎‡9 1‏
919 ‎‡a officialamericanthoracicsocietyeuropeanrespiratorysocietystatementpulmonaryfunctiontestinginpreschoolchildren‏ ‎‡A An official American Thoracic Society/European Respiratory Society statement: pulmonary function testing in preschool children‏ ‎‡9 1‏
919 ‎‡a officialamericanthoracicsocietyworkshopreportoptimallungfunctiontestsformonitoringcysticfibrosisbronchopulmonarydysplasiaandrecurrentwheezinginchildrenlessthan6yearsofage‏ ‎‡A An official American Thoracic Society workshop report: optimal lung function tests for monitoring cystic fibrosis, bronchopulmonary dysplasia, and recurrent wheezing in children less than 6 years of age.‏ ‎‡9 1‏
919 ‎‡a azithromycinadministeredforacutebronchiolitismayhaveaprotectiveeffectonsubsequentwheezing‏ ‎‡A Azithromycin administered for acute bronchiolitis may have a protective effect on subsequent wheezing‏ ‎‡9 1‏
919 ‎‡a azithromycintherapyinhospitalizedinfantswithacutebronchiolitisisnotassociatedwithbetterclinicaloutcomesarandomizeddoubleblindedandplacebocontrolledclinicaltrial‏ ‎‡A Azithromycin therapy in hospitalized infants with acute bronchiolitis is not associated with better clinical outcomes: a randomized, double-blinded, and placebo-controlled clinical trial.‏ ‎‡9 1‏
919 ‎‡a burdenofasthmaamonginnercitychildrenfromsouthernbrazil‏ ‎‡A Burden of asthma among inner-city children from Southern Brazil‏ ‎‡9 1‏
919 ‎‡a changesintheprevalenceofasthmaandallergicdiseasesamongbrazilianschoolchildren‏ ‎‡A Changes in the prevalence of asthma and allergic diseases among Brazilian schoolchildren‏ ‎‡9 1‏
919 ‎‡a changesintheprevalenceofasthmaandallergicdiseasesamongbrazilianschoolchildren1314yearsoldcomparisonbetweenisaacphases1and3‏ ‎‡A Changes in the prevalence of asthma and allergic diseases among Brazilian schoolchildren (13-14 years old): comparison between ISAAC Phases One and Three.‏ ‎‡9 1‏
919 ‎‡a chorioamnionitisandsubsequentlungfunctioninpreterminfants‏ ‎‡A Chorioamnionitis and subsequent lung function in preterm infants‏ ‎‡9 1‏
919 ‎‡a clinicalcharacteristicsofchildrenandadolescentswithseveretherapyresistantasthmainbrazil‏ ‎‡A Clinical characteristics of children and adolescents with severe therapy-resistant asthma in Brazil‏ ‎‡9 1‏
919 ‎‡a diagnosisofprimaryciliarydyskinesiaanofficialamericanthoracicsocietyclinicalpracticeguideline‏ ‎‡A Diagnosis of Primary Ciliary Dyskinesia. An Official American Thoracic Society Clinical Practice Guideline‏ ‎‡9 1‏
919 ‎‡a diagnosisofpulmonaryaspirationamousemodelusingastarchgranuletestinbronchoalveolarlavage‏ ‎‡A Diagnosis of pulmonary aspiration: a mouse model using a starch granule test in bronchoalveolar lavage.‏ ‎‡9 1‏
919 ‎‡a earlyterminationofexhalationeffectonspirometricparametersinhealthypreschoolchildren‏ ‎‡A Early termination of exhalation: effect on spirometric parameters in healthy preschool children‏ ‎‡9 1‏
919 ‎‡a effectofangiostrongyluscostaricensisextractoneosinophilicpulmonaryresponseinbalb100mice‏ ‎‡A Effect of Angiostrongylus costaricensis extract on eosinophilic pulmonary response in BALB/c mice‏ ‎‡9 1‏
919 ‎‡a effectofcontinuouspositiveairwaypressureonforcedexpiratoryflowsininfantswithtracheomalacia‏ ‎‡A Effect of continuous positive airway pressure on forced expiratory flows in infants with tracheomalacia.‏ ‎‡9 1‏
919 ‎‡a effectofdifferenthelminthextractsonthedevelopmentofasthmainmicetheinfluenceofearlylifeexposureandtheroleofil10response‏ ‎‡A Effect of different helminth extracts on the development of asthma in mice: The influence of early-life exposure and the role of IL-10 response.‏ ‎‡9 1‏
919 ‎‡a effectofpretermbirthonairwayfunctionandlunggrowth‏ ‎‡A Effect of preterm birth on airway function and lung growth.‏ ‎‡9 1‏
919 ‎‡a effectofyogurtcontainingbifidobacteriumanimalissubsplactisdn173010probioticondentalplaqueandsalivainorthodonticpatients‏ ‎‡A Effect of yogurt containing Bifidobacterium animalis subsp. lactis DN-173010 probiotic on dental plaque and saliva in orthodontic patients‏ ‎‡9 1‏
919 ‎‡a effectsofphysicalactivityintelomerelengthsystematicreviewandmetaanalysis‏ ‎‡A Effects of physical activity in telomere length: Systematic review and meta-analysis.‏ ‎‡9 1‏
919 ‎‡a evaluatingbronchodilatorresponseinpediatricpatientswithpostinfectiousbronchiolitisobliteransuseofdifferentcriteriaforidentifyingairwayreversibility‏ ‎‡A Evaluating bronchodilator response in pediatric patients with post-infectious bronchiolitis obliterans: use of different criteria for identifying airway reversibility.‏ ‎‡9 1‏
919 ‎‡a evaluationofairwayreactivityandimmunecharacteristicsasriskfactorsforwheezingearlyinlife‏ ‎‡A Evaluation of airway reactivity and immune characteristics as risk factors for wheezing early in life.‏ ‎‡9 1‏
919 ‎‡a flowlimitationininfantsassessedbynegativeexpiratorypressure‏ ‎‡A Flow limitation in infants assessed by negative expiratory pressure‏ ‎‡9 1‏
919 ‎‡a forcedexpiratoryflowsandvolumesininfantsnormativedataandlunggrowth‏ ‎‡A Forced expiratory flows and volumes in infants. Normative data and lung growth.‏ ‎‡9 1‏
919 ‎‡a forcedexpiratorymaneuversinveryyoungchildrenassessmentofflowlimitation‏ ‎‡A Forced expiratory maneuvers in very young children. Assessment of flow limitation‏ ‎‡9 1‏
919 ‎‡a geneticvariationinvascularendothelialgrowthfactoraandlungfunction‏ ‎‡A Genetic variation in vascular endothelial growth factor-a and lung function‏ ‎‡9 1‏
919 ‎‡a growthrateoflungfunctioninhealthypreterminfants‏ ‎‡A Growth rate of lung function in healthy preterm infants.‏ ‎‡9 1‏
919 ‎‡a helminthextractsinhibiteosinophilicinflammationinamurinemodelofallergicrhinitis‏ ‎‡A Helminth extracts inhibit eosinophilic inflammation in a murine model of allergic rhinitis‏ ‎‡9 1‏
919 ‎‡a impactof10valentpneumococcalnontypeablehaemophilusinfluenzaeprotein500conjugatevaccinephid105onchildhoodpneumoniahospitalizationsinbrazil2yearsafterintroduction‏ ‎‡A Impact of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) on childhood pneumonia hospitalizations in Brazil two years after introduction‏ ‎‡9 1‏
919 ‎‡a infectionofbalb100micewithangiostrongyluscostaricensisdecreasespulmonaryinflammatoryresponsetoovalbumin‏ ‎‡A Infection of BALB/c mice with Angiostrongylus costaricensis decreases pulmonary inflammatory response to ovalbumin‏ ‎‡9 1‏
919 ‎‡a intestinalhelminthinfestationisassociatedwithincreasedbronchialresponsivenessinchildren‏ ‎‡A Intestinal helminth infestation is associated with increased bronchial responsiveness in children‏ ‎‡9 1‏
919 ‎‡a levelsofth1andth2cytokinesinchildrenwithpostinfectiousbronchiolitisobliterans‏ ‎‡A Levels of Th1 and Th2 cytokines in children with post-infectious bronchiolitis obliterans‏ ‎‡9 1‏
919 ‎‡a neutrophilicairwayinflammationisamainfeatureofinducedsputuminnonatopicasthmaticchildren‏ ‎‡A Neutrophilic airway inflammation is a main feature of induced sputum in nonatopic asthmatic children.‏ ‎‡9 1‏
919 ‎‡a normalvaluesforrespiratorymusclestrengthinhealthypreschoolersandschoolchildren‏ ‎‡A Normal values for respiratory muscle strength in healthy preschoolers and school children‏ ‎‡9 1‏
919 ‎‡a nutritionalerrorsinthe1monthsoflifeandtheirassociationwithasthmaandatopyinpreschoolchildren‏ ‎‡A Nutritional errors in the first months of life and their association with asthma and atopy in preschool children‏ ‎‡9 1‏
919 ‎‡a peripheralglucocorticoidsensitivityinchildrenwithcontrolledpersistentasthma‏ ‎‡A Peripheral glucocorticoid sensitivity in children with controlled persistent asthma.‏ ‎‡9 1‏
919 ‎‡a plasmabrainderivedneurotrophicfactorlevelsareassociatedwithclinicalseverityinschoolagechildrenwithasthma‏ ‎‡A Plasma brain-derived neurotrophic factor levels are associated with clinical severity in school age children with asthma.‏ ‎‡9 1‏
919 ‎‡a plasticbronchitisinachildwiththalassemiaalpha‏ ‎‡A Plastic bronchitis in a child with thalassemia alpha‏ ‎‡9 1‏
919 ‎‡a tnfaandil10levelsintracheobronchiallavageofventilatedpreterminfantsandsubsequentlungfunction‏ ‎‡A TNF-a and IL-10 levels in tracheobronchial lavage of ventilated preterm infants and subsequent lung function‏ ‎‡9 1‏
919 ‎‡a prevalenceofsymptomsofsleepdisorderedbreathinginbrazilianschoolchildren‏ ‎‡A The prevalence of symptoms of sleep-disordered breathing in Brazilian schoolchildren.‏ ‎‡9 1‏
919 ‎‡a predictionequationsforspirometryin4to6yearoldchildren‏ ‎‡A Prediction equations for spirometry in four- to six-year-old children‏ ‎‡9 1‏
919 ‎‡a impactofrespiratorysyncytialvirusdiseasepreventiononpediatricasthma‏ ‎‡A The Impact of Respiratory Syncytial Virus Disease Prevention on Pediatric Asthma‏ ‎‡9 1‏
919 ‎‡a prevalenceandimpactofasthmainschoolchildreninthecityofcaxiasdosulrs‏ ‎‡A Prevalence and impact of asthma in schoolchildren in the city of Caxias do Sul-RS‏ ‎‡9 1‏
919 ‎‡a burdenofsinglevirusandviralcoinfectionsonseverelowerrespiratorytractinfectionsamongpreterminfantsaprospectivebirthcohortstudyinbrazil‏ ‎‡A The burden of single virus and viral coinfections on severe lower respiratory tract infections among preterm infants: a prospective birth cohort study in Brazil‏ ‎‡9 1‏
919 ‎‡a preventionofnewrespiratoryepisodesinchildrenwithrecurrentrespiratoryinfectionsanexpertconsensusstatement‏ ‎‡A Prevention of New Respiratory Episodes in Children with Recurrent Respiratory Infections: An Expert Consensus Statement‏ ‎‡9 1‏
919 ‎‡a spirometrycentilechartsforyoungcaucasianchildrentheasthmaukcollaborativeinitiative‏ ‎‡A Spirometry centile charts for young Caucasian children: the Asthma UK Collaborative Initiative‏ ‎‡9 1‏
919 ‎‡a rateconstantforforcedexpirationdecreaseswithlunggrowthduringinfancy‏ ‎‡A Rate constant for forced expiration decreases with lung growth during infancy‏ ‎‡9 1‏
919 ‎‡a severelowerrespiratorytractinfectionininfantsandtoddlersfromanonaffluentpopulationviraletiologyandcodetectionasriskfactors‏ ‎‡A Severe lower respiratory tract infection in infants and toddlers from a non-affluent population: viral etiology and co-detection as risk factors‏ ‎‡9 1‏
919 ‎‡a sensitivityofspirometricmeasurementstodetectairwayobstructionininfants‏ ‎‡A Sensitivity of spirometric measurements to detect airway obstruction in infants.‏ ‎‡9 1‏
919 ‎‡a riskfactorsforneedofmechanicalventilationinchildrenwithinfluenzaah1n1pdm09‏ ‎‡A Risk factors for need of mechanical ventilation in children with influenza A(H1N1)pdm09.‏ ‎‡9 1‏
919 ‎‡a rhinovirusandacutebronchiolitisinyounginfants‏ ‎‡A [Rhinovirus and acute bronchiolitis in young infants].‏ ‎‡9 1‏
919 ‎‡a respiratoryviralcoinfectionanddiseaseseverityinchildrenasystematicreviewandmetaanalysis‏ ‎‡A Respiratory viral coinfection and disease severity in children: A systematic review and meta-analysis‏ ‎‡9 1‏
919 ‎‡a recombinanthumandeoxyribonucleaseattenuatesoxidativestressinamodelofeosinophilicpulmonaryresponseinmice‏ ‎‡A Recombinant human deoxyribonuclease attenuates oxidative stress in a model of eosinophilic pulmonary response in mice‏ ‎‡9 1‏
919 ‎‡a recombinanthumandeoxyribonucleasetherapyimprovesairwayresistanceandreducesdnaextracellulartrapsinamurineacuteasthmamodel‏ ‎‡A Recombinant human deoxyribonuclease therapy improves airway resistance and reduces DNA extracellular traps in a murine acute asthma model‏ ‎‡9 1‏
919 ‎‡a reducedlungfunctioninhealthypreterminfantsinthe1monthsoflife‏ ‎‡A Reduced lung function in healthy preterm infants in the first months of life.‏ ‎‡9 1‏
919 ‎‡a referencerangesforinterrupterresistancetechniquetheasthmaukinitiative‏ ‎‡A Reference ranges for interrupter resistance technique: the Asthma UK Initiative.‏ ‎‡9 1‏
946 ‎‡a b‏ ‎‡9 1‏
996 ‎‡2 NDL|001189898
996 ‎‡2 LNB|LNC10-000336712
996 ‎‡2 BIBSYS|9005710
996 ‎‡2 CAOONL|ncf10469015
996 ‎‡2 SUDOC|251135942
996 ‎‡2 BIBSYS|1488830535933
996 ‎‡2 SUDOC|029269016
996 ‎‡2 LC|no2005008108
996 ‎‡2 SUDOC|082327068
996 ‎‡2 JPG|500232159
996 ‎‡2 J9U|987007457475805171
996 ‎‡2 BAV|495_349690
996 ‎‡2 BAV|495_349691
996 ‎‡2 ISNI|0000000077142665
996 ‎‡2 ISNI|0000000070920313
996 ‎‡2 LC|no2018015613
996 ‎‡2 LC|n 91002141
996 ‎‡2 BIBSYS|1707990462809
996 ‎‡2 NUKAT|n 2022200440
996 ‎‡2 LC|no2018067175
996 ‎‡2 NLA|000035567110
996 ‎‡2 LC|n 2015050789
996 ‎‡2 LC|no2010136459
996 ‎‡2 NDL|00738888
996 ‎‡2 LC|n 88621549
996 ‎‡2 DNB|171244230
996 ‎‡2 NLA|000035252773
996 ‎‡2 J9U|987007404549305171
996 ‎‡2 NUKAT|n 2003139794
996 ‎‡2 BNF|13474782
996 ‎‡2 ISNI|0000000054505857
996 ‎‡2 NTA|128495162
996 ‎‡2 DNB|1075549620
996 ‎‡2 CAOONL|ncf11194278
996 ‎‡2 ISNI|000000008405740X
996 ‎‡2 SZ|1067414789
996 ‎‡2 LC|nb 99052660
996 ‎‡2 ISNI|0000000083631764
996 ‎‡2 BNF|18174793
996 ‎‡2 BNF|15700315
996 ‎‡2 BIBSYS|90059304
996 ‎‡2 ISNI|0000000054262760
996 ‎‡2 ISNI|0000000074369362
996 ‎‡2 ISNI|0000000043392033
996 ‎‡2 RERO|A020140661
996 ‎‡2 RERO|A006436500
996 ‎‡2 SUDOC|236676415
996 ‎‡2 ISNI|0000000114674469
996 ‎‡2 J9U|987007456475905171
996 ‎‡2 LNB|LNC10-000092208
996 ‎‡2 SUDOC|129356212
996 ‎‡2 NUKAT|n 98000614
996 ‎‡2 NII|DA11724068
996 ‎‡2 LC|n 2008053638
996 ‎‡2 DNB|10849344X
996 ‎‡2 CAOONL|ncf10644797
996 ‎‡2 J9U|987007402454405171
996 ‎‡2 KRNLK|KAC200807186
996 ‎‡2 LC|no2010093559
996 ‎‡2 DNB|1324107413
996 ‎‡2 ISNI|0000000115918277
996 ‎‡2 DNB|114183317
996 ‎‡2 NII|DA00373868
996 ‎‡2 NUKAT|n 2009141576
996 ‎‡2 LC|n 88009220
996 ‎‡2 PTBNP|156705
996 ‎‡2 NUKAT|n 2005002451
996 ‎‡2 LC|no2021082547
996 ‎‡2 LC|n 90605925
996 ‎‡2 ISNI|0000000037655175
996 ‎‡2 BNF|17148765
996 ‎‡2 BIBSYS|41830
996 ‎‡2 N6I|vtls000010735
996 ‎‡2 ISNI|0000000383176724
996 ‎‡2 BIBSYS|12028681
996 ‎‡2 NTA|07508256X
996 ‎‡2 ISNI|0000000035910080
996 ‎‡2 BAV|495_287887
996 ‎‡2 RERO|A009312185
996 ‎‡2 LC|nb 99116083
996 ‎‡2 LC|nb2021000830
996 ‎‡2 LC|no2013051697
996 ‎‡2 SUDOC|077315804
996 ‎‡2 ISNI|0000000101373034
996 ‎‡2 DNB|136030645
996 ‎‡2 LC|n 88639481
996 ‎‡2 ISNI|0000000080595200
996 ‎‡2 JPG|500018578
996 ‎‡2 BNF|16577770
996 ‎‡2 BIBSYS|90830440
996 ‎‡2 NII|DA07744389
996 ‎‡2 BIBSYS|90763725
996 ‎‡2 SUDOC|145578461
996 ‎‡2 J9U|987007315964705171
996 ‎‡2 NII|DA17774604
996 ‎‡2 LC|n 96034279
996 ‎‡2 LC|n 79058341
996 ‎‡2 SUDOC|201071452
996 ‎‡2 LC|n 2011080877
996 ‎‡2 B2Q|0000014377
996 ‎‡2 CAOONL|ncf10642195
996 ‎‡2 NII|DA10688548
996 ‎‡2 CAOONL|ncf12114972
996 ‎‡2 SUDOC|202690342
996 ‎‡2 ISNI|0000000037293514
996 ‎‡2 ISNI|0000000402660213
996 ‎‡2 LC|no2019098921
996 ‎‡2 BIBSYS|14006639
996 ‎‡2 ISNI|0000000424901823
996 ‎‡2 CAOONL|ncf11337428
996 ‎‡2 ISNI|0000000051460382
996 ‎‡2 ISNI|0000000063684287
996 ‎‡2 CAOONL|ncf10075177
996 ‎‡2 ISNI|0000000076841085
996 ‎‡2 LC|n 85080076
996 ‎‡2 LC|n 50007165
996 ‎‡2 ISNI|0000000463376240
996 ‎‡2 LC|n 2013004326
996 ‎‡2 NTA|32208895X
996 ‎‡2 NUKAT|n 2017196870
996 ‎‡2 NDL|01203015
996 ‎‡2 NTA|138257639
996 ‎‡2 NTA|269084975
996 ‎‡2 NTA|394186389
996 ‎‡2 BIBSYS|8022533
996 ‎‡2 NII|DA17079796
996 ‎‡2 ISNI|0000000043076911
996 ‎‡2 DNB|1344166563
996 ‎‡2 LC|n 2008020038
996 ‎‡2 SUDOC|19188295X
996 ‎‡2 RERO|A011108745
996 ‎‡2 BIBSYS|11078666
996 ‎‡2 BIBSYS|4025693
996 ‎‡2 NTA|315548827
996 ‎‡2 DBC|87097961864644
996 ‎‡2 LC|nb2010026883
996 ‎‡2 BIBSYS|1592544498297
996 ‎‡2 NSK|000093105
996 ‎‡2 BLBNB|001574256
996 ‎‡2 RERO|A025098476
996 ‎‡2 ISNI|0000000394408105
996 ‎‡2 J9U|987007376397105171
996 ‎‡2 ISNI|0000000043232857
996 ‎‡2 DNB|1028027893
996 ‎‡2 LC|n 89605411
996 ‎‡2 SUDOC|113639481
996 ‎‡2 LC|no 97053865
996 ‎‡2 CAOONL|ncf10643911
996 ‎‡2 BNF|17142372
996 ‎‡2 J9U|987007269530505171
996 ‎‡2 LC|n 95041174
996 ‎‡2 LC|no2019116314
996 ‎‡2 NKC|stk2007383196
996 ‎‡2 RERO|A003429899
996 ‎‡2 DNB|136030734
996 ‎‡2 SUDOC|16975023X
996 ‎‡2 BNE|XX1218703
996 ‎‡2 NII|DA18724394
996 ‎‡2 NTA|29748897X
996 ‎‡2 LC|no2003047800
996 ‎‡2 LC|no2015068016
996 ‎‡2 LC|no 98079363
996 ‎‡2 ISNI|0000000401925144
996 ‎‡2 BIBSYS|90898503
996 ‎‡2 BNF|15004020
996 ‎‡2 DNB|1268649287
996 ‎‡2 LC|n 96054634
996 ‎‡2 LC|n 92043333
996 ‎‡2 BNF|16775415
996 ‎‡2 SIMACOB|269465699
996 ‎‡2 BNF|12093191
996 ‎‡2 BIBSYS|1022102
996 ‎‡2 W2Z|1615360583639
996 ‎‡2 DNB|1041836074
996 ‎‡2 ISNI|0000000133567095
996 ‎‡2 NUKAT|n 2017076429
996 ‎‡2 J9U|987007430259805171
996 ‎‡2 LC|no2024096105
996 ‎‡2 J9U|987007339155505171
996 ‎‡2 SUDOC|185979432
996 ‎‡2 RERO|A027655582
996 ‎‡2 LC|no 89012112
996 ‎‡2 NUKAT|n 2019005349
996 ‎‡2 NSK|000667105
996 ‎‡2 LC|nb2014003939
996 ‎‡2 DNB|14263168X
996 ‎‡2 DNB|1122069405
996 ‎‡2 LC|nb2006021595
996 ‎‡2 BIBSYS|14016693
996 ‎‡2 LC|nb2013017681
996 ‎‡2 BIBSYS|3030556
996 ‎‡2 LC|n 2012074913
996 ‎‡2 CAOONL|ncf12120847
996 ‎‡2 SUDOC|167412876
996 ‎‡2 BIBSYS|1542227323818
996 ‎‡2 J9U|987007414680405171
996 ‎‡2 DNB|1079912088
996 ‎‡2 JPG|500271122
996 ‎‡2 BIBSYS|90524019
996 ‎‡2 DNB|1034964887
996 ‎‡2 RERO|A025828894
996 ‎‡2 NTA|41110859X
996 ‎‡2 LC|nb2005015990
996 ‎‡2 LC|no2024037172
996 ‎‡2 LC|n 87878884
996 ‎‡2 NKC|jn20000605116
996 ‎‡2 ISNI|0000000463376232
996 ‎‡2 ISNI|0000000038197540
996 ‎‡2 DNB|1138949566
996 ‎‡2 NTA|160438004
996 ‎‡2 LC|no2005009091
996 ‎‡2 DNB|1193435943
996 ‎‡2 LC|nb2002017659
996 ‎‡2 BIBSYS|2122154
996 ‎‡2 ISNI|0000000116623278
996 ‎‡2 ERRR|12520469
996 ‎‡2 NUKAT|n 2015094179
996 ‎‡2 LNB|LNC10-000033983
996 ‎‡2 ISNI|0000000039853773
996 ‎‡2 J9U|987007384411405171
996 ‎‡2 ISNI|0000000043735083
996 ‎‡2 J9U|987007586337205171
996 ‎‡2 NUKAT|n 2007117996
996 ‎‡2 ISNI|0000000036897412
996 ‎‡2 NTA|21580919X
996 ‎‡2 LC|nb2015014459
996 ‎‡2 B2Q|0000034483
996 ‎‡2 NII|DA06032702
996 ‎‡2 DNB|1120543150
996 ‎‡2 NUKAT|n 2012168454
996 ‎‡2 LC|nr 91031631
996 ‎‡2 NII|DA13164598
996 ‎‡2 RERO|A027632046
996 ‎‡2 LC|no2024114668
996 ‎‡2 LC|n 96803486
996 ‎‡2 LC|no2017111007
996 ‎‡2 DNB|174002270
996 ‎‡2 CAOONL|ncf10376058
996 ‎‡2 LC|no2004079567
996 ‎‡2 BAV|495_124406
996 ‎‡2 J9U|987007270085005171
996 ‎‡2 LC|n 88657896
996 ‎‡2 ISNI|0000000486607558
996 ‎‡2 NKC|jo20221143175
996 ‎‡2 NKC|xx0249012
996 ‎‡2 LC|n 90628354
996 ‎‡2 LC|no2013142611
996 ‎‡2 LC|n 2012035307
996 ‎‡2 DNB|1067414789
996 ‎‡2 NTA|134225074
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏